Home Safety / Products / Chemotherapy Drug Handling and Occupational Cyclophosphamide Exposure (Antineoplastic Mutagenicity, Surface Contamination, Closed-System Transfer Devices)

Chemotherapy Drug Handling and Occupational Cyclophosphamide Exposure (Antineoplastic Mutagenicity, Surface Contamination, Closed-System Transfer Devices) — household safety profile

High risk

Cyclophosphamide and other antineoplastic agents are among the most hazardous occupational chemical exposures in healthcare, with documented mutagenic, teratogenic, and carcinogenic effects in workers who prepare, administer, or clean up after chemotherapy treatments.

What is this product?

Cyclophosphamide and other antineoplastic agents are among the most hazardous occupational chemical exposures in healthcare, with documented mutagenic, teratogenic, and carcinogenic effects in workers who prepare, administer, or clean up after chemotherapy treatments. Cyclophosphamide — a nitrogen mustard alkylating agent — is the most extensively studied hazardous drug in occupational settings: surface contamination studies consistently detect cyclophosphamide on pharmacy compounding surfaces, IV poles, patient bedrails, and even toilet seats at concentrations of 0.005-10 ng/cm2. Urine biomonitoring studies demonstrate measurable cyclophosphamide in 10-20% of healthcare workers handling the drug, even when using standard PPE. The drug is mutagenic in the Ames test, classified IARC Group 1 (carcinogenic to humans), and causes chromosomal aberrations in exposed healthcare workers at rates 2-3 times higher than unexposed controls. NIOSH designates it as a hazardous drug requiring engineering controls, and USP General Chapter 800 mandates closed-system transfer devices (CSTDs), biological safety cabinets, and specialized PPE for all handling.

What's in it

Click any compound name for its full safety profile, regulatory consensus, and exposure data.

Hazardous Drug

Frequently asked questions

No FAQs generated.

Look up Chemotherapy Drug Handling and Occupational Cyclophosphamide Exposure (Antineoplastic Mutagenicity, Surface Contamination, Closed-System Transfer Devices) in the home app

Search by ingredient, browse by category, or compare to alternatives in the live app.

Open in home View raw API data

Reference data, not professional advice. Aggregates publicly available regulatory and scientific information. Why we built ALETHEIA →